Unbiased Analysis of Today's Healthcare Issues
That is the title of a paper published today with my co-authors Felicia Forma, Kevin Chiu, Jason Shafrin, Dusica Hadzi Boskovic, and S Phani Veeranki. The subtitle is: Caregiver preferences for health technology tools to monitor medication adherence among patients with serious mental illness. The paper abstract is below: Background Adherence to antipsychotic medication is…
That is the title of my recent paper in Advances in Therapy along with co-authors Christian Jackisch, Federico Manevy, Suzanne Frank, and Nicki Roberts. This is a case study of the fixed-dose combination therapy of pertuzumab and trastuzumab as a subcutaneous injection compared to previous treatments which were administered via infusion. The abstract is below.…
If you are attending the ISPOR Europe 2021 conference, please check out my panels on the following topics: “Addressing Payment Challenges for Alzheimer’s Disease-Modifying Therapies” on December 1, 16:00-17:00 CET with Jakub Hlavka, Howard Thom, and Adrian Towse. “Challenges in Quantifying the Value of Digital Therapeutics” on December 2, 11:00-12:00 CET with Wayne Burton, Megan…
Mark your calendars and be sure to register: I will be speaking on two panels at the upcoming ISPOR Europe 2021 virtual conference. These panels include: “Addressing Payment Challenges for Alzheimer’s Disease-Modifying Therapies” on December 1, 16:00-17:00 CET and “Challenges in Quantifying the Value of Digital Therapeutics” on December 2, 11:00-12:00 CET. Further event details…
This Sunday I had a very enjoyable experience giving a guest lecture at the University of Southern California’s Healthcare Decision Analysis program (specifically class HCDA 520). The topic of the class was “Health Economics & Outcomes Methodology” and my lecture was on “Novel approaches to quantifying value”. Thank you to Professor Daniel Tomaszewski for inviting…
That is the title of a recent commentary published in the Journal of Clinical Pathways with my colleague David Gruber. New digital technologies have the potential to greatly improve our healthcare system on multiple fronts. Telemedicine allowed many patients to communicate with their doctors during the COVID-19 pandemic; during the height of the pandemic, 30% of…
That is the title of a recent paper published in the Journal of Medical Economics with Syvart Dennan, Oliver Diaz, Kelly Birch, Jennifer Cai, Jennifer Sung, and Paula Machado. The subtitle is: A case study of increased graft survival on the US kidney transplant waitlist. The abstract is below: Aim: To quantify the wider impacts…
That is the finding from a white paper from the Schizophrenia and Psychosis Action Alliance titled “Societal Costs of Schizophrenia & Related Disorders“. I am a co-author on the paper. Below is a summary of the findings: …the societal costs of schizophrenia were estimated to be $281.6 billion in 2020…Direct costs for individuals living with…
I will be on a panel tomorrow for the Wall Street Journal‘s Global Food Forum. My panel will include and Hakim Bouzamondo (Divisional VP, Global Research and Development, Nutrition at Abbott) and Dr. Leah Gramlich, (Gastroenterologist and Physician Nutrition Specialist at the Royal Alexandra Hospital in Alberta Canada) as well as myself. This discussion will…
In an article in Health Affairs, Rick van der Vegte and I argue that in four specific cases, the answer is yes. …the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) developed a “value flower,” which aims to more comprehensively capture all elements of value relevant for measuring the value of a new health technology.…